Remilk is a technology company.
Remilk has raised $131.0M across 2 funding rounds.
Remilk has raised $131.0M in total across 2 funding rounds.
Remilk has raised $131.0M in total across 2 funding rounds.
Remilk's investors include Hanaco Ventures, Left Lane Capital, fresh.fund, Hummingbird Ventures, Prime Ventures.
Remilk is an Israeli biotechnology company founded in 2019 that produces animal-free dairy proteins using precision fermentation, enabling real dairy products like milk, cheese, yogurt, and ice cream without cows.[1][4][5] It serves food manufacturers and major brands such as General Mills and Gad Dairies, solving the environmental and ethical challenges of traditional dairy production by creating chemically identical proteins that use 1% of the land, 5% of the water, and emit 4-97% fewer greenhouse gases while eliminating lactose, cholesterol, hormones, and antibiotics.[1][2][6] Remilk has raised over $150 million, secured regulatory approvals in the US, Israel, Canada, and Singapore, launched products like cow-free cream cheese and "The New Milk" in markets including the US and Israel, and is building the world's largest precision fermentation facility in Denmark to scale production.[1][2][5]
Remilk was founded in 2019 in Israel by CEO Aviv Wolff and CTO Dr. Ori Cohavi, a biochemist, with the goal of decoupling dairy production from livestock while preserving taste, texture, and nutrition.[4][5][6] The idea emerged from copying cow milk protein genes (casein and whey) into yeast cells, turning them into efficient "protein factories" via precision fermentation—a modern twist on ancient fermentation methods.[5][6][8] Early traction included raising over $150 million in funding, developing patented scalable manufacturing, achieving FDA Self Affirmed GRAS status, and partnering with giants like General Mills for animal-free cheese and Gad Dairies for Israel's first cow-free milk launch in 2024, marking pivotal commercialization steps.[2][3][5]
Remilk rides the precision fermentation wave in alternative proteins, projected to capture 11% ($290B) of the global protein market by 2035 amid rising demand for sustainable food tech.[1] Timing aligns with climate pressures on dairy—responsible for significant emissions and resource use—fueled by regulatory pushes for net-zero (e.g., UN 2050 goals) and consumer shifts toward ethical, low-impact products.[1][6] Market forces like partnerships with incumbents (General Mills, Gad) accelerate adoption, bypassing plant-based limitations by offering "real dairy" that integrates seamlessly into existing supply chains.[2][3] Remilk influences the ecosystem by proving animal-free dairy at scale, inspiring competitors, and normalizing biotech in food, potentially disrupting the $800B+ dairy industry.[1][5]
Remilk is poised for explosive growth with its Denmark mega-facility enabling global supply, expanding partnerships, and new product categories beyond cream cheese and milk.[1][2] Trends like tightening emissions regulations, precision fermentation advancements, and alternative protein mainstreaming will propel it, potentially capturing significant dairy market share as costs align with traditional methods.[1][2] Its influence may evolve from innovator to infrastructure provider, reshaping dairy toward sustainability while maintaining the "real deal" appeal that hooked consumers from day one.[7]
Remilk has raised $131.0M across 2 funding rounds. Most recently, it raised $120.0M Series B in January 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2022 | $120.0M Series B | Hanaco Ventures, Left Lane Capital | |
| Dec 1, 2020 | $11.0M Series A | fresh.fund, Hummingbird Ventures, Prime Ventures |